Acid Ceramidase-IN-2
Acid Ceramidase-IN-2 (compound 1) is an acid ceramidase inhibitor with potentially antiproliferative and cytostatic activities. Moreover, human acid ceramidase is overexpressed in prostate cancer cells, indicating potential anti-tumor effect of Acid Ceramidase-IN-2. And Acid Ceramidase-IN-2 hydrolysis can be inhibited by 3 a-ketoamides GT85, GT98 and GT99 inhibits in vitro[1].
Product Specifications
CAS Number
[1005497-03-9]
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
Ceramidase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/acid-ceramidase-in-2.html
Purity
99.0
Solubility
10 mM in DMSO
Smiles
CCCCCCCCCCCCCCCC(N[C@@H](CO)[C@H](O)CCOC1=CC=C(C=CC(O2)=O)C2=C1)=O
Molecular Formula
C30H47NO6
Molecular Weight
517.70
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Explore Other Products
Browse additional items from our catalog
Mouse Monoclonal Kallikrein 3/PSA Antibody (1A7 (same as 1A7G6B6))
NeuroD (BETA2, BHF-1, MODY6, NEUROD, bHLHa3, Class A Basic Helix-loop-helix Protein 3)
LMO2 (Rhombotin-2, Cysteine-rich Protein TTG-2, LIM Domain Only Protein 2, LMO-2, T-cell Translocation Protein 2, RBTN2, RBTNL1, RHOM2, TTG2) (MaxLight 405)
